Medicare Enrolled
Dr. Michael Schwartz, M.D.
Optician · Miami Beach, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Schwartz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schwartz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Schwartz
Dr. Michael Schwartz is an optician specialist in Miami Beach, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Schwartz performed 2,034 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Schwartz received a total of $28,730 from 93 pharmaceutical and/or device companies across 1589 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schwartz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 38% volume in FL
$28,730 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 61671 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗2,034
Medicare services
Top 38% in FL for optician
Not available
Unique patients (not deduplicated)
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,308 | $52 | $165 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
423 | $78 | $252 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
118 | $67 | $228 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
111 | $105 | $433 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
61 | $107 | $449 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
13 | $61 | $262 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$28,730
Total received (2018-2024)
Avg $4,104/year across 7 years
Top 6% in FL for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
93
Companies
1,589
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,216
2023
$4,408
2022
$3,267
2021
$3,431
2020
$3,347
2019
$4,452
2018
$4,609
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$439
PFIZER INC.
$431
Celgene Corporation
$401
Janssen Biotech, Inc.
$361
Daiichi Sankyo Inc.
$346
AstraZeneca Pharmaceuticals LP
$307
Regeneron Healthcare Solutions, Inc.
$196
GlaxoSmithKline, LLC.
$188
Merck Sharp & Dohme LLC
$185
ABBVIE INC.
$179
GENZYME CORPORATION
$179
SpringWorks Therapeutics, Inc.
$146
Incyte Corporation
$134
ARRAY BIOPHARMA INC
$114
Pharmacosmos Therapeutics Inc.
$105
E.R. Squibb & Sons, L.L.C.
$88
Genentech USA, Inc.
$83
TAIHO ONCOLOGY, INC.
$83
Mirati Therapeutics, Inc.
$79
Rigel Pharmaceuticals, Inc.
$77
Takeda Pharmaceuticals U.S.A., Inc.
$76
BeiGene USA, Inc.
$74
SERVIER PHARMACEUTICALS LLC
$67
Gilead Sciences, Inc.
$66
Astellas Pharma US Inc
$66
EMD Serono, Inc.
$61
Lilly USA, LLC
$53
TerSera Therapeutics LLC
$51
Sumitomo Pharma America, Inc.
$48
Blueprint Medicines Corporation
$43
Myriad Genetic Laboratories, Inc.
$41
Deciphera Pharmaceuticals Inc.
$40
SOBI, INC
$40
Exelixis Inc.
$38
Agios Pharmaceuticals, Inc.
$37
Eisai Inc.
$35
Alexion Pharmaceuticals, Inc.
$35
JAZZ PHARMACEUTICALS INC.
$33
Kite Pharma, Inc.
$28
MorphoSys, US Inc.
$24
Genmab U.S., Inc.
$24
Adaptive Biotechnologies Corporation
$20
Fennec Pharmaceuticals, Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$17
Stemline Therapeutics Inc.
$16
Apellis Pharmaceuticals, Inc.
$15
Tempus AI, Inc
$14
RECORDATI_RARE_DISEASES_INC.
$14
Top 3 companies account for 24.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,371
Celgene Corporation
$1,802
Novartis Pharmaceuticals Corporation
$1,772
Genentech USA, Inc.
$1,722
PFIZER INC.
$1,597
Janssen Biotech, Inc.
$1,444
Merck Sharp & Dohme Corporation
$1,269
E.R. Squibb & Sons, L.L.C.
$1,186
Incyte Corporation
$1,077
Daiichi Sankyo Inc.
$961
Astellas Pharma US Inc
$864
Amgen Inc.
$603
GENZYME CORPORATION
$567
Seagen Inc.
$550
GlaxoSmithKline, LLC.
$487
Merck Sharp & Dohme LLC
$485
Exelixis Inc.
$464
Lilly USA, LLC
$461
Pharmacyclics LLC, An AbbVie Company
$421
Regeneron Healthcare Solutions, Inc.
$353
Takeda Pharmaceuticals U.S.A., Inc.
$325
Janssen Pharmaceuticals, Inc
$318
Bayer HealthCare Pharmaceuticals Inc.
$248
Gilead Sciences, Inc.
$245
ABBVIE INC.
$243
AVEO Pharmaceuticals, Inc.
$233
ARRAY BIOPHARMA INC
$232
Rigel Pharmaceuticals, Inc.
$227
Kite Pharma, Inc.
$223
EMD Serono, Inc.
$213
Pharmacosmos Therapeutics Inc.
$203
Eisai Inc.
$203
Myriad Genetic Laboratories, Inc.
$196
Deciphera Pharmaceuticals Inc.
$185
Epizyme, Inc.,
$181
Clovis Oncology, Inc.
$178
SERVIER PHARMACEUTICALS LLC
$170
Sumitomo Pharma America, Inc.
$169
Pharmacyclics LLC, an AbbVie Company
$165
Mirati Therapeutics, Inc.
$161
Array BioPharma Inc.
$161
AbbVie Inc.
$155
Janssen Scientific Affairs, LLC
$152
SpringWorks Therapeutics, Inc.
$146
Myovant Sciences Inc.
$138
EISAI INC.
$138
Seattle Genetics, Inc.
$132
TESARO, Inc.
$128
Adaptive Biotechnologies Corporation
$128
Foundation Medicine, Inc.
$127
EUSA Pharma (US) LLC
$124
Taiho Oncology, Inc.
$119
Kyowa Kirin, Inc.
$113
TerSera Therapeutics LLC
$110
MorphoSys, US Inc.
$110
AbbVie, Inc.
$105
TAIHO ONCOLOGY, INC.
$103
BeiGene USA, Inc.
$101
Ipsen Biopharmaceuticals, Inc
$95
Blueprint Medicines Corporation
$94
SOBI, INC
$92
Stemline Therapeutics Inc.
$87
Helsinn Therapeutics (U.S.), Inc.
$87
Karyopharm Therapeutics Inc.
$85
Alexion Pharmaceuticals, Inc.
$84
Teva Pharmaceuticals USA, Inc.
$77
Dova Pharmaceuticals
$76
ADC Therapeutics America, Inc.
$76
Janssen Products, LP
$65
MEDIVATION FIELD SOLUTIONS LLC
$65
G1 Therapeutics, Inc.
$60
Acceleron Pharma, Inc.
$55
Verastem, Inc.
$52
CTI BioPharma Corp.
$52
Agios Pharmaceuticals, Inc.
$50
Dendreon Pharmaceuticals LLC
$44
AMAG Pharmaceuticals, Inc.
$39
Aveo Pharmaceuticals, Inc.
$35
JAZZ PHARMACEUTICALS INC.
$33
PUMA BIOTECHNOLOGY, INC.
$30
Shire North American Group Inc
$29
Jazz Pharmaceuticals Inc.
$25
Genmab U.S., Inc.
$24
Sun Pharmaceutical Industries Inc.
$22
Fennec Pharmaceuticals, Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$17
Medtronic USA, Inc.
$15
Apellis Pharmaceuticals, Inc.
$15
Aurobindo Pharma USA, Inc.
$15
Tempus AI, Inc
$14
RECORDATI_RARE_DISEASES_INC.
$14
Advanced Accelerator Applications
$14
SANOFI-AVENTIS U.S. LLC
$12
Top 3 companies account for 20.7% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AKEEGA · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · BAVENCIO · BENDEKA · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Empaveli · Enhertu · Epkinly · Erleada · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Neulasta · Nexavar · Non-Covered Product · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · QINLOCK · QUZYTTIR · REBLOZYL · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SANDOSTATIN · SARCLISA · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNCHROMED · Sylvant · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
711
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
MOUNT SINAI MEDICAL CENTER OF FLORIDA, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Schwartz is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Schwartz experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Schwartz performed 1,308 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Schwartz receive payments from pharmaceutical companies?
Yes. Dr. Schwartz received a total of $28,730 from 93 companies across 1,589 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schwartz's costs compare to other opticians in Miami Beach?
Dr. Schwartz's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schwartz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Miami Beach
Browse opticians in Miami Beach ranked by procedure volume and transparency data.
Highest volume
Top Opticians in FL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in FL
Which FL opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology